Press Releases
Chris LeGrand Chosen to Participate on DIA Program Committee
DURHAM, N.C., April 6, 2004—The Drug Information Association (DIA) has
selected Chris LeGrand, President of Constella Health Sciences, as a program
committee member for its 40th annual exhibition and conference to be held June
13-17 in Washington, D.C.
Over the past year, LeGrand has worked with the committee to develop more
than 300 sessions related to clinical data management, clinical trials
management, good clinical practices, regulatory affairs and several other
drug-related topics. LeGrand is the Clinical Data Management (CDM) track chair
and will moderate five sessions at the June event, which is expected to attract
more than 8,000 people.
"DIA-sponsored events give pharmaceutical and biotechnology companies an
opportunity to explore the latest processes, systems and technologies in the
field," said LeGrand, who has planned and moderated DIA programs for the past
three years. "It is also a collaborative effort with our Clinical Informatics
business, which exhibits and speaks at these events each year."
In addition to his involvement at DIA's large annual meeting, LeGrand also
served on the program committee and chaired three sessions at the 19th Annual
DIA CDM Symposium and Exhibition, held March 21-24 in Philadelphia. This year's
event, attended by more than 600 people, focused on the people, processes and
technologies that comprise the core functions of CDM in today's global business
environment.
LeGrand chaired the following sessions at the CDM event:
- Systems 1: IT and CDM Square Off—This session explored how the IT and CDM
communities—two groups that speak different languages and have conflicting
priorities—can seek to find interdependencies, expose their different viewpoints
and priorities, and seek to find mutual respect and common ground.
The debate-style setting featured IT and CDM representatives.
- Systems 2: The Future of CDM: Collaboration and Exchange Tools—This session
explored real-world examples of how online project communities, electronic
trials and collaboration tools are being used today, and how these tools are
setting the future of clinical trials and CDM.
- Database Systems CDISC: Implementation and Impact—This session provided
information on how CDISC—now the de facto information standard for collecting,
managing and exchanging clinical research—is impacting legacy structures and
work processes.
About Constella Group
Constella Group is a leading provider of professional health services worldwide,
celebrating 20 years of enhancing human health through innovative science,
technology and knowledge solutions. Constella's two business units-Health
Sciences and Clinical Informatics-create and provide health intelligence
to help industry and government clients identify and address critical issues
affecting human health. With Constella as the parent company, these business
units comprise dynamic points of collaboration that build support, create
momentum and add value from idea to impact across the full continuum of human
health.
The company's 700 employees serve clients from company headquarters in Durham,
N.C., and from offices in Atlanta; Morgantown, W.Va.; and Bethesda, Frederick
and Silver Spring, Md.
About DIA
DIA is the premier drug-related
association, attracting more than 8,000 attendees each year at its annual
exhibition and conference. This year, DIA will conduct approximately 120
workshops and seminars across the world. It also sponsors the Annual EuroMeeting
and other large annual meetings such as Clinical Data Management (North
America), Electronic Document Management (North America) and Clinical Data
Management (Europe).
